Strategic Partnerships Aequus is actively expanding its pipeline through in-licensing and distribution agreements and aims to commercialize internal programs in Canada while pursuing strategic partnerships worldwide. This creates sales opportunities through co-marketing, licensing deals, and international distribution arrangements with specialty ophthalmology, neurology, and psychiatry products.

Canadian Focus Current go-to-market activities are Canada-centric with a focus on highly specialized therapeutic areas. This presents a sales channel opportunity to leverage local payer insights, physician networks, and patient advocacy groups to accelerate adoption of Zimed PF and other differentiated products in Canadian markets.

Recent Product Wins Launch of Zimed PF and recognition of early revenue indicate validation of the product strategy in ophthalmology. There is opportunity to upsell related delivery systems, expand indications, or pursue additional access programs and formulary placements with ophthalmology specialists and eye-care providers.

Clinical-Commercial Alignment Management emphasizes bridging clinical development with payer and physician insights. This supports targeted value propositions focusing on improved adherence through advanced delivery systems, which can be leveraged to approach hospital formularies, specialty clinics, and patient support programs.

Operational Readiness Recent leadership additions and partnerships with distributors (e.g., Scope Ophthalmics) signal capable operations for scaling partnerships and commercialization. This enables BD initiatives around co-promotion, regional distribution deals, and accelerated time-to-market for new products in ophthalmology and beyond.